Home › Glycogen Storage Disease Type II › North Carolina
Glycogen Storage Disease Type II clinical trials in North Carolina
8 studies for Glycogen Storage Disease Type II are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
- Duke University School of Medicine - Early Phase Research Unit, Durham
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT07354724A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- Duke University, Durham
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Jul 20, 2026 · NCT07282847Pompe Disease Registry Protocol
- Carolinas Medical Center Hospital- Site Number : 840065, Charlotte
- Duke University Medical Center Genetics Dept- Site Number : 840037, Durham
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00231400Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Duke University Medical Center, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07123155Pompe Pregnancy Sub-Registry
- Duke University Medical Center Genetics Dept- Site Number : 840037, Durham
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT00567073Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- Duke University Medical Center, Durham
RecruitingObservational study
All ages · All sexes · Updated Apr 8, 2026 · NCT01665326A Global Prospective Observational Registry of Patients With Pompe Disease
- Duke University Medical Center, Durham
RecruitingObservational study
All ages · All sexes · Updated Mar 10, 2026 · NCT06121011Cognitive and Neurological Pathologies in Pompe Disease
- Duke University Medical Center, Durham
RecruitingObservational study
Ages 0 to 18 · All sexes · Updated Mar 4, 2026 · NCT04639336From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.